Swedish Mobile Colposcope gains Medical Registration in Ethiopa

Cervical cancer is the second most common cancer in women in Ethiopia and many women does not have access to screening, diagnosis and treatment. The Swedish Medtech company Gynius AB, has partnered with Setema Limited in Addis Abeba to promote gold standard diagnostics of cervical cancer by the Gynocular mobile colposcope and the T2D colposcopy software..

- Cervical cancer is a major health issue in Ethiopia, says Deputy General Manager Tsehaye Alemayehu. I am glad our company can make a difference by introducing the Gynocular Mobile Colposcope, and save women's lives. We are exited to plan ahead for the market introduction and have local experts recommending the device for cervical cancer screening.

The Gynocular Mobile Colposcope has now gained official Certificate of Registration of Gynius by the Food, Medicine and Healthcare Administration and Control Authority of Ethiopia.

-  The official registration of the Gynocular in Ethiopia is important, says Gynius' Vice CEO Elisabeth Wikström Shemer. Our goal is to bring goal standard diagnostics to women in any setting, and the Ethiopian registration show a commitment to women in this region and  increase the standards for accurate diagnosis and treatment of cervical cancer.

Interested in a Gynocular Mobile Colposcope in Ethiopia?

Please contact:

Tsehaye Alemayehu, Deputy General Manager (Mob.: +251-9 11 212439)

Wondewossen Assefa, Technical Manager (Mob.: +251-922727381)

Zelalem Anagaw, Medical Devices Dept. Manager (Mob.: +251-921945740)

The physical address is

SETEMA LIMITED PLC

Setema Building R. No. 2014, Gurde Shola

P.O. Box 12882

Addis Ababa, Ethiopia